Release Date: 31/10/11 11:42 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 116.62KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%